JPMorgan Chase & Co. cut its QuidelOrtho stake by 85.6% in Q3, holding 125,501 shares worth $3.7 million. Despite mixed analyst sentiment and insider buying, QDEL faces a "Reduce" consensus and has a target price of $31.50, following disappointing net margins.

NodeGuardian

2026-04-16 18:33:51

Abstract generation in progress

JPMorgan Chase & Co. significantly reduced its stake in QuidelOrtho Corporation ($QDEL) in Q3 by selling 85.6% of its shares, retaining 125,501 shares valued at approximately $3.7 million. Despite insider buying by director Matthew Strobeck and CEO Brian Blaser, analyst sentiment for QDEL is mixed, with a “Reduce” consensus and a target price of $31.50. The company recently surpassed EPS and revenue expectations but reported a negative net margin.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes

Reward
1
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
169.44K Popularity
#
Gate13thAnniversaryLive
612.41K Popularity
#
AltcoinsRallyStrong
7.3M Popularity
#
AnthropicvsOpenAIHeatsUp
1.05M Popularity
#
KalshiFacesNevadaRegulatoryClash
451.66K Popularity

Sitemap

QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co.

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin